Acyloxy Nitroso Compounds Inhibit LIF Signaling in Endothelial Cells and Cardiac Myocytes: Evidence That STAT3 Signaling Is Redox-Sensitive

• Carlos Zgheib,

  Affiliation Departments of Pharmacology and Toxicology, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Mazen Kurdi,

  Affiliation Department of Chemistry and Biochemistry, Faculty of Sciences, Lebanese University, Rafic Hariri Educational Campus, Hadath, Lebanon

  ⨯
• Fouad A. Zouein,

  Affiliation Departments of Pharmacology and Toxicology, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Barak W. Gunter,

  Affiliation Departments of Pharmacology and Toxicology, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Brian A. Stanley,

  Affiliation Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America

  ⨯
• Joe Zgheib,

  Affiliation Department of Medicine, Division of Cardiology, Centre Hospitalier Universitaire de Nancy, Brabois, France

  ⨯
• Damian G. Romero,

  Affiliation Department of Biochemistry, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• S. Bruce King,

  Affiliation Department of Chemistry, Wake Forest University, Winston-Salem, North Carolina, United States of America

  ⨯
• Nazareno Paolocci,

  Affiliations Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America, Clinical Medicine Department, Section of General Pathology, University of Perugia, Perugia, Italy

  ⨯
• George W. Booz

  * E-mail: gbooz@umc.edu

  Affiliation Departments of Pharmacology and Toxicology, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯